EU Approves Biotech Co. Illumina's Plan To Divest Grail
European Union antitrust authorities on Friday approved Illumina's plan to sell off Grail, the latest development in a saga that saw the biotech company reverse course and agree to offload the cancer-screening company after authorities...To view the full article, register now.
Already a subscriber? Click here to view full article